24th March 2016 – Nonacus Successfully Closes First Round of Investment Funding

We are pleased to announce that we have successfully closed our first round of investment funding from private investors who share our vision of developing high quality, clinically focussed, consumable products that enable clinicians and their staff to take advantage of the accessibility and information now available from cell free DNA.

We look forward to the coming year and creating innovative technologies with the aim of advancing prenatal healthcare through the use of cell free DNA in prenatal diagnostics.